Camidanlumab tesirine
Camidanlumab tesirine
Camidanlumab tesirine (pronunciation: kam-i-dan-lu-mab te-si-rine) is a monoclonal antibody-drug conjugate used in the treatment of various types of cancer. It is currently under investigation for its potential use in the treatment of solid tumors.
Etymology
The name "Camidanlumab tesirine" is derived from the components of the drug. "Camidanlumab" refers to the monoclonal antibody component, while "tesirine" refers to the cytotoxic drug that is conjugated to the antibody.
Mechanism of Action
Camidanlumab tesirine works by binding to a specific protein on the surface of cancer cells. Once bound, the drug is internalized by the cell, where the cytotoxic drug is released. This causes damage to the cancer cell, leading to its death.
Related Terms
- Monoclonal antibody: A type of protein made in the lab that can bind to substances in the body, including cancer cells.
- Cytotoxic drug: A medication that kills cells, especially cancer cells.
- Solid tumor: An abnormal mass of tissue that usually does not contain cysts or liquid areas. Solid tumors may be benign or malignant.
See Also
External links
- Medical encyclopedia article on Camidanlumab tesirine
- Wikipedia's article - Camidanlumab tesirine
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski